About TEZCAT Laboratories:
TEZCAT Laboratories is committed to the research and development of novel biologic-based therapies to treat Ras cancers with high unmet needs, such as pancreatic cancer.  The first-generation technology has been optimized for tumor-specific killing, solid tumor penetration, and manufacturability. 
​

Born out of NYU Langone Health, our team is committed to refining and delivering the leading-edge technology from bench to bedside. TEZCAT Laboratories has participated in the 2018 Entrepreneurship Lab (ELab) Program, an initiative of NYC's Economic Development Corporation (NYCEDC).